Johnson and Johnson Pharmaceutical Research and Development
Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
VerImmune and Janssen enter research collaboration
VerImmune announced that it had entered into a research collaboration with Janssen Research & Development to conduct feasibility studies evaluating VerImmune's AIR-ViP technology platform.
2021
ConcertAI and Janssen expand data science collaboration
ConcertAI announced an expansion of its multi-year collaboration with Janssen Research & Development across several disease-area programs. The collaboration applies AI, data science, and real-world clinical data to inform clinical strategies and support study designs, while also seeking to broaden trial access and strengthen trial diversity.
2020
FDA approves Tremfya for active psoriatic arthritis
The U.S. Food and Drug Administration approved Tremfya as a treatment for adults with active psoriatic arthritis. Janssen announced the approval; MorphoSys said it through its licensee.